Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Chronic Pain in Breast Cancer Survivors
NCT01912612Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Oct 2013
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine in chronic pain, sponsored by University of Michigan Rogel Cancer Center. Started Oct 2013; status: completed.
02
Drugs
duloxetine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01912612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01912612.